Ca 15.3

Sample Type -
Pre-test Information -
Report Delivery -
₹ Price ₹ 1450
This evaluation predicts early recurrence of carcinoma breast treated among women. This test is useful especially for serial testing with prior stage II or III breast cancer who are clinically considered free of disease.

Frequently Asked Questions (FAQs)

CA 15.3 test uses two monoclonal antibodies (115D8 and DF3) which react with a circulating CA 15.3 antigen expressed in human breast cancer cell CA 15.3 test is used for the monitoring of therapy and disease progression for patients with diagnosed malignant tumors A decrease in the CA 15.3 concentration can indicate a positive response to therapy and therefore good prognosis. A constant increase in CA 15.3 concentration often reflects evolution of the tumor and a poor response to therapy Results from this test should be interpreted as part of a complete clinical profile and in conjunction with other diagnostic techniques CA 15.3 assay cannot be used as a screening test for cancer